Clinical Trial Update: Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia [Phase 2]

View source ↗

Summary

Phase 2 trial of intranasal carbon dioxide for symptomatic treatment of classical trigeminal neuralgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Trigeminal Neuralgia

Drugs mentioned

• Nasal carbon dioxide (carbon dioxide)

Snippet

Sponsor: Capnia, Inc. | Conditions: Trigeminal Neuralgia | Phase 2 | Status: COMPLETED